KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. - Abstract - Europe PMC
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
Bi-allelic MCM10 variants associated with immune dysfunction and cardiomyopathy cause telomere shortening
KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. - Abstract - Europe PMC
Frontiers MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
JCI - Identification of direct transcriptional targets of NFATC2 that promote β cell proliferation
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
Over-Activation of Minichromosome Maintenance Protein 10 Promotes Genomic Instability in Early Stages of Breast Cancer
Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth
KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. - Abstract - Europe PMC
Comprehensive analysis of lncRNAs N6-methyladenosine modification in colorectal cancer
